BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

PharusDx Secures Exclusive License for Breakthrough Pancreatic Cancer Biomarkers from City of Hope

Pharus Diagnostics ("PharusDx") has announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be...

February 16, 2024 | News

Cathay Biotech and 3P.COM Forge Groundbreaking Joint Venture to Propel Sustainable Composite Innovations

In a strategic move towards sustainable innovation, Cathay Biotech Inc. of China and 3P.COM Co. Limited of South Korea have signed a landmark joint venture...

February 09, 2024 | News

Innovent Biologics Advances Novel Weight Management Drug Mazdutide with NDA Acceptance in China

This groundbreaking achievement marks mazdutide as the first GLP-1R/GCGR dual agonist to successfully complete Phase 3 trials in support of an NDA ...

February 08, 2024 | Regulatory

Complete Genomics and seqWell Partner to Enhance DNA Sequencing Solutions

The collaboration will focus on ensuring compatibility between seqWell-developed products and the entire Complete Genomics next-generation sequencing (NGS)...

February 08, 2024 | News

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

January 26, 2024 | Interview

PRISM BioLab Secures 1.5 Billion Yen in Series C Funding for Advancing Protein-Protein Interaction Technologies

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

January 25, 2024 | News

PeproMene Bio Reports Successful B-ALL Treatment in Phase 1 Trial at City of Hope

This result adds to the presentation of PeproMene Bio's clinical trial of PMB-CT01 in relapsed/refractory non-Hodgkin's lymphoma at last month's Ameri...

January 18, 2024 | News

FUST Lab's DEBREX Nano-Emulsion Equipment Launches in Japan

Dispersion/emulsification technology (technology for mixing two or more immiscible substances) is a key technology used in various productions such as cosm...

January 16, 2024 | News

Novogene Expands Global Presence with Increased PacBio Revio Fleet for Enhanced Long-Read Sequencing Applications

Novogene aims to strengthen its service offerings in long-read sequencing applications with PacBio latest Revio sequencer. As an early adopter of PacBio Re...

January 10, 2024 | News

Medison Pharma to Commercialize Regeneron's Libtayo® in Multiple Countries

Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, adv...

January 09, 2024 | News

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

January 08, 2024 | News

JW Therapeutics' supplemental license application for Carteyva® in relapsed or refractory Mantle Cell Lymphoma has been accepted by the NMPA.

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immun...

January 05, 2024 | News

Turn Biotechnologies Unveils Enhanced eTurna™ Platform to Address Industry's Delivery Challenges

Company announces development of novel ionizable lipids and stabilizing components eTurna™ delivery platform expected to improve safety, redu...

January 04, 2024 | News

Atal Incubation Centre - CCMB and Thermo Fisher Scientific Join Forces to Drive Innovation in Startup Ecosystem

At the heart of this partnership lies the establishment of a cutting-edge laboratory, outfitted with state-of-the-art, high-end equipment generously provid...

January 03, 2024 | News

Stay Connected